<unk>  is neutral in terms of androgenic activity, meaning that contraceptive pills containing<unk>  do not exhibit the androgenic side effects (e.g., acne, hirsutism) sometimes associated with second-generation contraceptive pills such as those containing levonorgestrel. The estrogen dosage in third-generation contraceptive pills (including those containing<unk>  is lower than that in second-generation oral contraceptives, reducing the likelihood of weight gain, breast tenderness, and migraine. Third-generation oral contraceptives are also suitable for use in patients with diabetes or lipid disorders because they have minimal impact on blood glucose levels and the lipid profile.<unk>  is also available in combination with estradiol for use in menopausal hormone therapy. Available forms Contraceptive products containing<unk>  include: * Melodene-15, Mirelle, and Minesse which contain 15 μg of ethinylestradiol and 60 μg of<unk> ; * Meliane, Sunya, Femodette, and Millinette 20/75 which contain 20 μg of ethinylestradiol and 75 μg of<unk> ; and * Gynera, Minulet, Femoden, Femodene, Katya and Millinette 30/75 which contain 30 μg of ethinylestradiol and 75 μg of<unk> .
Gestodene
Hexestrol
Mestanolone
Formestane
Fosfestrol
Dimestrol
Gestrinone
Dienestrol